These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 20196618

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effect of amyloid associated proteins on the expression of genes involved in amyloid-β clearance by adult human astrocytes.
    Mulder SD, Veerhuis R, Blankenstein MA, Nielsen HM.
    Exp Neurol; 2012 Jan; 233(1):373-9. PubMed ID: 22101005
    [Abstract] [Full Text] [Related]

  • 4. Design of Peptide Substrate for Sensitively and Specifically Detecting Two Aβ-Degrading Enzymes: Neprilysin and Angiotensin-Converting Enzyme.
    Chen PT, Chen CL, Lin LT, Lo CH, Hu CJ, Chen RP, Wang SS.
    PLoS One; 2016 Jan; 11(4):e0153360. PubMed ID: 27096746
    [Abstract] [Full Text] [Related]

  • 5. Insulin-signaling Pathway Regulates the Degradation of Amyloid β-protein via Astrocytes.
    Yamamoto N, Ishikuro R, Tanida M, Suzuki K, Ikeda-Matsuo Y, Sobue K.
    Neuroscience; 2018 Aug 10; 385():227-236. PubMed ID: 29932983
    [Abstract] [Full Text] [Related]

  • 6. Molecular basis of selective amyloid-β degrading enzymes in Alzheimer's disease.
    Żukowska J, Moss SJ, Subramanian V, Acharya KR.
    FEBS J; 2024 Jul 10; 291(14):2999-3029. PubMed ID: 37622248
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Aggregation and catabolism of disease-associated intra-Abeta mutations: reduced proteolysis of AbetaA21G by neprilysin.
    Betts V, Leissring MA, Dolios G, Wang R, Selkoe DJ, Walsh DM.
    Neurobiol Dis; 2008 Sep 10; 31(3):442-50. PubMed ID: 18602473
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Powering Amyloid Beta Degrading Enzymes: A Possible Therapy for Alzheimer's Disease.
    Sikanyika NL, Parkington HC, Smith AI, Kuruppu S.
    Neurochem Res; 2019 Jun 10; 44(6):1289-1296. PubMed ID: 30806879
    [Abstract] [Full Text] [Related]

  • 13. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E, Torrance M, Mante M, Adame A, Paulino A, Rose JB, Crews L, Moessler H, Masliah E.
    J Neurosci Res; 2006 May 15; 83(7):1252-61. PubMed ID: 16511867
    [Abstract] [Full Text] [Related]

  • 14. Differential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer's disease.
    Dorfman VB, Pasquini L, Riudavets M, López-Costa JJ, Villegas A, Troncoso JC, Lopera F, Castaño EM, Morelli L.
    Neurobiol Aging; 2010 Oct 15; 31(10):1743-57. PubMed ID: 19019493
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Leptin inhibits amyloid β-protein degradation through decrease of neprilysin expression in primary cultured astrocytes.
    Yamamoto N, Tanida M, Ono Y, Kasahara R, Fujii Y, Ohora K, Suzuki K, Sobue K.
    Biochem Biophys Res Commun; 2014 Feb 28; 445(1):214-7. PubMed ID: 24508800
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders.
    Caccamo A, Oddo S, Sugarman MC, Akbari Y, LaFerla FM.
    Neurobiol Aging; 2005 May 28; 26(5):645-54. PubMed ID: 15708439
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.